Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2007
05/30/2007CN1970764A Porcine beta-interferon recombinant adenovirus and its construction method and application
05/30/2007CN1970763A Shortened anti-oncogene p53 capable of increasing sensitivity of human lung cancer cell to antineoplastics
05/30/2007CN1970762A 人类肝脏相关基因 Human liver-related genes
05/30/2007CN1970761A 人类肝脏相关基因 Human liver-related genes
05/30/2007CN1970760A 人类肝脏相关基因 Human liver-related genes
05/30/2007CN1970759A 人类肝脏相关基因 Human liver-related genes
05/30/2007CN1970758A Expression sequence tag having expression in human liver
05/30/2007CN1970757A Expression sequence tag having expression in human liver
05/30/2007CN1970756A Human liver related gene
05/30/2007CN1970755A Human liver related gene
05/30/2007CN1970754A Human liver related gene
05/30/2007CN1970753A Method for extracting whole genome of abyssal sediment
05/30/2007CN1970752A Method for recovery of DNA by using magnetic nanocomposite and reagent kit therefor
05/30/2007CN1970751A Method for extracting whole genome DNA from Apocymum venetum L. leaves
05/30/2007CN1970750A Garget-resistant milk cow breeding method
05/30/2007CN1970749A Process for preparing prion protein gene-free domestic animals
05/30/2007CN1970748A Method for femtosecond laser fusion of phaffiafhodozyma cell
05/30/2007CN1970746A Bifunctional variants of recombinant tissue-type plasminogen activator with platelet aggregation inhibitory activity
05/30/2007CN1970744A Corn embryosperm ADP- glucose pyrophosphorylase mutant and its screening method and application
05/30/2007CN1970741A Super engineering bacteria, expressed detoxification enzyme thereof, and construction method and application therefor
05/30/2007CN1970730A 黑曲霉 Aspergillus niger
05/30/2007CN1970591A Biodegradable crosslinked polyethylenimine and its uses
05/30/2007CN1970574A Double function infusion protein for thrombolysis and anticoagulation , its preparation method and uses
05/30/2007CN1970573A Neutrality monoclonal antibody 3E1 for resisting ricin, its preparation method and uses
05/30/2007CN1970571A G-csf analog compositions and methods
05/30/2007CN1970570A Yeast engineered bacteria for expressing recombinant prawn protein Pen9 and its preparation method and uses
05/30/2007CN1970569A Rice leaf curl-outward gene and its uses
05/30/2007CN1970568A Alpha-alcohol soluble protein gene nucleic acid sequence and its uses
05/30/2007CN1970081A Avian influenza virus marking vaccine, preparation process and application thereof
05/30/2007CN1970078A Peptides and related molecules that bind to tall-1
05/30/2007CN1970077A Peptides and related molecules that bind to tall-1
05/30/2007CN1318605C System and method for detecting biological and chemical material
05/30/2007CN1318604C Amplification process
05/30/2007CN1318596C Vectors based on recombinant defective viral gene group, and their use in formulation of vaccines
05/30/2007CN1318595C Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells
05/30/2007CN1318594C Recombinant human VEGF and bFGF eukaryon expression vector, fused protein and applications thereof
05/30/2007CN1318593C Nucleic acid sequences to proteins involved in tocopherol synthesis
05/30/2007CN1318592C O type foot and mouth disease virus DNA vaccine and its preparing method
05/30/2007CN1318591C Immune tbid gene and its coded protein and application
05/30/2007CN1318590C Human protooncogene KG-20 and protein encoded therein
05/30/2007CN1318589C Method for preparing mammal cell kinetin synthetic inhibitory factor
05/30/2007CN1318588C Osteoprotegerine
05/30/2007CN1318587C Recombination preparation method of amidating Exendin-4 polypeptide
05/30/2007CN1318586C Method for the in vitro synthesis of short double stranded RNAs
05/30/2007CN1318585C Monolithic matrix for separating nucleic acids by reverse-phase into-pair high performance liquid chromatography
05/30/2007CN1318584C Baciallus thuringiensis engineering bacterium Go33A and preparing method thereof
05/30/2007CN1318579C Gene engineering method for raising plant useful secondary substance content
05/30/2007CN1318576C Targeted cytolysis of HIV-infected cells by chimerical CD4 receptor bearing cells
05/30/2007CN1318575C Protein conformational disease cell model and its use
05/30/2007CN1318448C Recombined full length human brain red element, preparation method and application thereof
05/30/2007CN1318443C Methods for refolding proteins containing free cysteine residues
05/30/2007CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases
05/30/2007CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases
05/30/2007CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof
05/30/2007CN1317952C Treatment of corn seeds with clothianidin
05/29/2007WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions
05/29/2007USRE39663 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
05/29/2007USPP17761 Campanula plant named ‘Royal Wave’
05/29/2007US7225083 Determination antagonist, moderators; three-dimensional models
05/29/2007US7225079 System and method for automated matched ion polynucleotide chromatography
05/29/2007US7223909 Genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, an N-terminal portion containing plastid transit peptide portion fused to a second ketolase enzyme portion
05/29/2007US7223907 Cotton event MON15985 and compositions and methods for detection thereof
05/29/2007US7223905 Plant vitamin E biosynthetic enzymes
05/29/2007US7223904 Plant gene sequences II
05/29/2007US7223903 Protein kinase stress-related proteins and methods of use in plants
05/29/2007US7223902 Gene expression of nucleic acid construct into a host cell comprising polynucleotide encoding polypeptide having a beta -glucosidase catalytic activity; genetic engineering; alcoholic beverages
05/29/2007US7223901 Soybean FGAM synthase promoters useful in nematode control
05/29/2007US7223858 Truncated aggrecanase molecules
05/29/2007US7223856 Therapy for nervous system degradation
05/29/2007US7223855 Transforming chimera gene; culture product
05/29/2007US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis
05/29/2007US7223853 Secreted frizzled related protein fragments
05/29/2007US7223852 Nucleic acids encoding TRAIN-R: a cysteine rich member of the TNF-receptor family
05/29/2007US7223850 For use in diagnosis and therapy of disease
05/29/2007US7223849 For inhibiting neoplastic cell growth in a human or mouse
05/29/2007US7223846 Urocortin proteins and uses thereof
05/29/2007US7223840 Antimicrobial peptide
05/29/2007US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders
05/29/2007US7223838 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2007US7223834 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
05/29/2007US7223743 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
05/29/2007US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1
05/29/2007US7223740 isolated host cell; treatment of arterial diseases, comprising intramuscularly administering a vector
05/29/2007US7223739 Adjuvanted genetic vaccines
05/29/2007US7223601 Genetic engineered protein
05/29/2007US7223600 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination
05/29/2007US7223599 Immortalization of human post-mitotic cells
05/29/2007US7223598 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
05/29/2007US7223597 Anti-apoptosis genes and methods of use thereof
05/29/2007US7223594 Immunogens; replication-defective; antibodies; host cells; kits
05/29/2007US7223593 Anticancer agents; gene coding immunomoderator cytokine protein
05/29/2007US7223589 Bacterium for the production of 2′-deoxyribonucleoside
05/29/2007US7223588 Microorganisms and methods for overproduction of DAHP by cloned Pps gene
05/29/2007US7223587 Gene conferring lysozyme insensitivity to Corynebacterium
05/29/2007US7223586 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth
05/29/2007US7223582 Esterase, its DNA, its overexpression and production of optically active aryl propionic acids using the same
05/29/2007US7223581 Expression vector comprising nucleotide sequences coding adenosine triphosphatase for use in improving organismal energy metabolism
05/29/2007US7223580 N-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
05/29/2007US7223579 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity
05/29/2007US7223578 Canine COX-1 nucleic acid molecules and fragments thereof